Yifeng Luo

1.5k total citations
33 papers, 1.0k citations indexed

About

Yifeng Luo is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Yifeng Luo has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Yifeng Luo's work include COVID-19 Clinical Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Yifeng Luo is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Yifeng Luo collaborates with scholars based in China, United States and India. Yifeng Luo's co-authors include Hui Li, Canmao Xie, Timothy S. Blackwell, Bryan J. Williams, Yubiao Guo, Weiping Tan, Xinyan Huang, Pei‐Fen Chen, Chunlong Yang and Rui-Ming Liu and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Yifeng Luo

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifeng Luo China 16 546 235 223 147 124 33 1.0k
Xinying Xue China 17 356 0.7× 266 1.1× 266 1.2× 43 0.3× 129 1.0× 54 1.0k
Lingyun Guo China 18 401 0.7× 113 0.5× 134 0.6× 95 0.6× 51 0.4× 79 982
Zhijun Jie China 18 349 0.6× 209 0.9× 224 1.0× 24 0.2× 146 1.2× 74 909
Xuan Xu China 21 773 1.4× 290 1.2× 140 0.6× 165 1.1× 94 0.8× 63 1.4k
Chunguang Yang China 17 276 0.5× 91 0.4× 174 0.8× 39 0.3× 98 0.8× 82 1.0k
Tsunehiro Shimizu Japan 16 747 1.4× 100 0.4× 75 0.3× 77 0.5× 68 0.5× 40 1.2k
Qianwen Li China 15 416 0.8× 165 0.7× 304 1.4× 29 0.2× 78 0.6× 50 1.3k
Seung Ok Lee South Korea 22 570 1.0× 332 1.4× 332 1.5× 23 0.2× 68 0.5× 83 1.6k
Thomas J. Gniadek United States 14 152 0.3× 51 0.2× 82 0.4× 87 0.6× 47 0.4× 36 705
Chuxiao Shao China 13 218 0.4× 120 0.5× 75 0.3× 89 0.6× 39 0.3× 65 641

Countries citing papers authored by Yifeng Luo

Since Specialization
Citations

This map shows the geographic impact of Yifeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Luo more than expected).

Fields of papers citing papers by Yifeng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Luo. The network helps show where Yifeng Luo may publish in the future.

Co-authorship network of co-authors of Yifeng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng Luo. A scholar is included among the top collaborators of Yifeng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng Luo. Yifeng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Ruijie, Yifeng Luo, Penghao Guo, et al.. (2025). Clinical evaluation of a multiplex droplet digital PCR for diagnosing suspected bloodstream infections: a prospective study. Frontiers in Cellular and Infection Microbiology. 14. 1489792–1489792. 3 indexed citations
2.
Ye, Xiangrong, et al.. (2025). Genome-wide CRISPR/Cas9 screening identifies key profibrotic regulators of TGF-β1-induced epithelial-mesenchymal transformation and pulmonary fibrosis. Frontiers in Molecular Biosciences. 12. 1507163–1507163. 1 indexed citations
3.
Ye, Xiangrong, et al.. (2024). Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs. Clinical and Experimental Medicine. 24(1). 157–157. 2 indexed citations
4.
Luo, Yifeng, Qian Zhou, Xinyan Huang, et al.. (2023). Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19. BMC Infectious Diseases. 23(1). 443–443.
5.
Zhou, Rui, Bo Qiu, Mai Xiong, et al.. (2023). Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049). International Journal of Radiation Oncology*Biology*Physics. 117(2). 387–399. 8 indexed citations
6.
Wang, Yang, Ruizhi Wang, Bin Huang, et al.. (2023). Epidemiological and laboratory characteristics of Omicron infection in a general hospital in Guangzhou: a retrospective study. Frontiers in Public Health. 11. 1289668–1289668. 1 indexed citations
8.
Luo, Yifeng, Gang Niu, Hui Yi, et al.. (2021). Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo. Redox Biology. 42. 101908–101908. 25 indexed citations
9.
Luo, Yifeng, et al.. (2021). Machine learning predictive model for severe COVID-19. Infection Genetics and Evolution. 90. 104737–104737. 28 indexed citations
10.
Zhao, Qi, Yifeng Luo, Mi Tian, et al.. (2021). Activating transcription factor 3 involved in Pseudomonas aeruginosa PAO1-induced macrophage senescence. Molecular Immunology. 133. 122–127. 10 indexed citations
11.
Ma, Jieyi, Hui Han, Ying Huang, et al.. (2021). METTL1/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression. Molecular Therapy. 29(12). 3422–3435. 189 indexed citations
12.
Liu, Yangli, Weiping Tan, Haihong Chen, et al.. (2021). Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19. BMC Infectious Diseases. 21(1). 79–79. 37 indexed citations
13.
15.
Xiong, Mai, et al.. (2018). Chylothorax and constrictive pericarditis in a woman due to generalized lymphatic anomaly: a case report. Journal of Cardiothoracic Surgery. 13(1). 59–59. 4 indexed citations
16.
Li, Hui, Yifeng Luo, Yongsheng Wang, et al.. (2018). Using ROS as a Second Messenger, NADPH Oxidase 2 Mediates Macrophage Senescence via Interaction with NF‐κB during Pseudomonas aeruginosa Infection. Oxidative Medicine and Cellular Longevity. 2018(1). 9741838–9741838. 34 indexed citations
18.
Li, Hui, Yifeng Luo, Bryan J. Williams, Timothy S. Blackwell, & Canmao Xie. (2012). Structure and function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to novel therapies. International Journal of Medical Microbiology. 302(2). 63–68. 181 indexed citations
19.
Luo, Yifeng, et al.. (2011). The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology. 16(6). 1000–1004. 36 indexed citations
20.
Luo, Yifeng. (2008). The Association of Apnea-hypopnea Indices with Body Mass Index in Patients with OSAS. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026